Thrombolex, Inc.

medical devices

About

Thrombolex, Inc. is a medical device company based in New Britain, Pennsylvania, founded in 2016. The company specializes in the design, development, and marketing of innovative endovascular catheters that utilize unique pharmaco-mechanical technologies to treat arterial and venous thromboembolic conditions. Thrombolex aims to enhance clinical outcomes for patients suffering from blood clots by allowing physicians to customize treatment approaches. The flagship BASHIR™ Endovascular Catheter platform combines mechanical and pharmacological mechanisms to restore blood flow and deliver thrombolytic drugs effectively. The BASHIR™ family includes various catheter models tailored for different vessel sizes and thrombus burdens, such as the Standard BASHIR™ Catheters and the S-B Catheter. Thrombolex's technology was developed in collaboration with Dr. Riyaz Bashir, a vascular medicine expert, and the company actively markets multiple FDA-cleared devices while maintaining a strong research and development pipeline for future innovations.

Technologies

OutlookWordPress.orgGoogle Tag ManagerGoogle Font APIreCAPTCHAGravity FormsNginxYouTubeMobile FriendlyTypekitVimeoIoTRemoteAI

Keywords

medical equipment manufacturingvascular blood flowthrombus managementon-the-table pharmacomechanical lysisvascular accesscatheter-based therapysegmental thrombolytics deliverymechanical thrombolysisthrombolytics deliveryservicespersonalized treatmentclinical outcomeshybrid mechanism of actionpulmonary embolism therapythrombus fragmentationmedical devicesb2bendovascular catheterfda-cleared devicespatient careinfusion technologyvascular devicemedical technologyvascular imagingvascular interventioncustomizable treatment devicesvascular intervention innovationvascular healthinterventional radiologyclot fragmentation

Location

75 Britain Dr, Doylestown, Pennsylvania, United States, 18901

Related Companies

Companies in the same industry